PARADIGM HEALTH PARTNERS WITH FDA TO REVOLUTIONIZE CLINICAL TRIAL DATA REGULATORY REVIEW
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 16 hours ago
0mins
Should l Buy PAR?
Source: moomoo
Collaboration Announcement: Paradigm Health has announced a collaboration with the FDA to enhance the regulatory review process for clinical trial data.
Focus on Clinical Trials: The partnership aims to streamline the evaluation of clinical trial data, potentially improving the efficiency of bringing new treatments to market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PAR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PAR
Wall Street analysts forecast PAR stock price to rise
7 Analyst Rating
6 Buy
1 Hold
0 Sell
Strong Buy
Current: 14.050
Low
42.00
Averages
56.40
High
77.00
Current: 14.050
Low
42.00
Averages
56.40
High
77.00
About PAR
PAR Technology Corporation is a foodservice technology company engaged in providing omnichannel cloud-based software and hardware solutions to the restaurant industry, including quick service, fast casual, table service, and the retail industry. It offers a suite of software and hardware solutions, including point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. Its subscription services are grouped into two product lines: Engagement Cloud and Operator Cloud. Engagement Cloud includes Punchh and PAR Ordering products and services, Plexure for international customer loyalty and engagement, and PAR Retail (including GoSkip) products and services, and fuel retailers. Operator Cloud, which includes PAR POS and TASK for front-of-house, PAR Pay for payments, and PAR OPS - a suite of back-of-house solutions that combine Delaget and Data Central product offerings.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
PARADIGM HEALTH PARTNERS WITH FDA TO REVOLUTIONIZE CLINICAL TRIAL DATA REGULATORY REVIEW
Collaboration Announcement: Paradigm Health has announced a collaboration with the FDA to enhance the regulatory review process for clinical trial data.
Focus on Clinical Trials: The partnership aims to streamline the evaluation of clinical trial data, potentially improving the efficiency of bringing new treatments to market.
See More
PAR Technology Corporation to Report Q1 Earnings on May 7, 2026
- Earnings Announcement: PAR Technology Corporation is set to release its Q1 financial results on May 7, 2026, at 4:00 p.m. ET, followed by an investor presentation and conference call, highlighting the company's commitment to transparency and investor relations.
- Live Webcast: The earnings conference call will be webcast live, allowing investors to access the event through the PAR Technology Investor Relations website, showcasing the company's efforts in digital communication and enhancing investor engagement.
- Post-Event Recording: A recording of the webcast will be available on the company’s website after the event, ensuring that investors who cannot participate live can still access critical information, thereby improving information accessibility.
- Company Overview: PAR Technology Corporation focuses on delivering an intelligent operating platform for multi-unit brands, integrating mission-critical software and hardware to enhance efficiency and profitability, reflecting the company's strategic positioning in a highly competitive market.
See More
ClearBridge Small-Cap Strategy Outperforms Benchmark in Q1 2026
- Strong Quarterly Performance: The ClearBridge Small-Cap Strategy outperformed its benchmark in Q1 2026, as the Russell 2000 Index only gained 0.9%, highlighting the fund's effective investment selection and management capabilities.
- New Positions Established: During Q1 2026, the fund established new positions in Parsons, PAR Technology, Descartes Systems, Prosperity Bancshares, and the abrdn Physical Precious Metals Basket Shares ETF, indicating confidence in their future growth potential.
- Exit Strategy: In the same quarter, the fund exited positions in Stride, Corcept Therapeutics, Valaris, and others, demonstrating its agile investment strategy and responsiveness to market dynamics.
- Earnings Target Confirmation: Independent Bank targets a net interest margin of 3.90%-3.95% for Q4 2026 while reaffirming a 1.40% return on assets goal, reflecting confidence in its future financial performance.
See More
PAR Technology Launches PAR Intelligence Platform
- Platform Launch: PAR Technology has introduced the PAR Intelligence platform, designed to enhance profitability for multi-unit operators by leveraging a unique data advantage accumulated over two decades, covering over 150,000 locations and processing 12 billion transactions annually.
- Execution Capability: Unlike traditional AI solutions that stop at insights, PAR Intelligence executes high-impact actions to bridge the 3.6x profitability gap between the best and worst stores, thereby improving overall business performance.
- Diverse Agent Functions: The platform features multiple AI-driven agents, such as the Insights Agent and Offers Agent, which automatically identify operational gaps and generate targeted marketing campaigns, reducing manual effort and increasing operational efficiency.
- Future Expansion Plans: PAR Technology plans to continue expanding the capabilities of the intelligence platform in the coming months by adding more agents and deeper orchestration, aiming to enhance the commercial performance of multi-unit operations and ensure that every store's profitability potential is fully realized.
See More
US Stocks Performance Review and Outlook
- Employment Data Expectations: ADP is set to release employment data at 8:15 a.m. ET, with a consensus estimate of 39,000 new jobs in the private sector, which will provide a crucial indicator of economic health and could influence investor confidence and market trends.
- Retail Sales Growth: Retail sales figures are expected to be released at 8:30 a.m., with a general forecast of a 0.5% increase, a data point that will directly impact consumer spending and the outlook for economic recovery, potentially guiding a market rebound.
- Corporate Earnings Dynamics: Cal-Maine, Conagra, and Lamb Weston are scheduled to report earnings before the bell, with Cal-Maine's stock flat over the past three months, Conagra down 9%, and Lamb Weston showing no significant change, all of which will affect investor sentiment towards the food sector.
- Market Performance Review: In the first quarter, the Russell 2000 index rose by 0.58%, making it the best performer among major indices, while the S&P 500 and Nasdaq 100 fell by 4.63% and 5.98%, respectively, reflecting market volatility and cautious investor sentiment.
See More
U.S. Stocks Decline Amid Escalating Geopolitical Tensions
- Oil Price Surge: The escalation of geopolitical tensions between the U.S. and Iran has pushed Brent crude oil prices above $100 per barrel, leading to significant declines in major indices and severely rattling investor confidence.
- Consumer Confidence Decline: The University of Michigan's consumer survey indicates a drop to a three-month low, with year-ahead inflation expectations rising to 3.8%, reflecting households' concerns about the economic outlook, which may suppress consumer spending.
- Poor Stock Performance: Hardware & Infrastructure company Pure Storage (NYSE:PSTG) fell 6.1%, while PAR Technology (NYSE:PAR) and IMAX (NYSE:IMAX) dropped 5.4% and 5% respectively, indicating a weakening market sentiment towards these companies.
- Uncertain Economic Outlook: Richmond Fed President Tom Barkin noted that the 'fog of war' has deepened economic uncertainty, and historically, oil price shocks are highly correlated with recessions, potentially leading to reduced corporate investment and hiring, further straining an already fragile economy.
See More
PARADIGM HEALTH PARTNERS WITH FDA TO REVOLUTIONIZE CLINICAL TRIAL DATA REGULATORY REVIEW
Collaboration Announcement: Paradigm Health has announced a collaboration with the FDA to enhance the regulatory review process for clinical trial data.
Focus on Clinical Trials: The partnership aims to streamline the evaluation of clinical trial data, potentially improving the efficiency of bringing new treatments to market.
See More
PAR Technology Corporation to Report Q1 Earnings on May 7, 2026
- Earnings Announcement: PAR Technology Corporation is set to release its Q1 financial results on May 7, 2026, at 4:00 p.m. ET, followed by an investor presentation and conference call, highlighting the company's commitment to transparency and investor relations.
- Live Webcast: The earnings conference call will be webcast live, allowing investors to access the event through the PAR Technology Investor Relations website, showcasing the company's efforts in digital communication and enhancing investor engagement.
- Post-Event Recording: A recording of the webcast will be available on the company’s website after the event, ensuring that investors who cannot participate live can still access critical information, thereby improving information accessibility.
- Company Overview: PAR Technology Corporation focuses on delivering an intelligent operating platform for multi-unit brands, integrating mission-critical software and hardware to enhance efficiency and profitability, reflecting the company's strategic positioning in a highly competitive market.
See More
ClearBridge Small-Cap Strategy Outperforms Benchmark in Q1 2026
- Strong Quarterly Performance: The ClearBridge Small-Cap Strategy outperformed its benchmark in Q1 2026, as the Russell 2000 Index only gained 0.9%, highlighting the fund's effective investment selection and management capabilities.
- New Positions Established: During Q1 2026, the fund established new positions in Parsons, PAR Technology, Descartes Systems, Prosperity Bancshares, and the abrdn Physical Precious Metals Basket Shares ETF, indicating confidence in their future growth potential.
- Exit Strategy: In the same quarter, the fund exited positions in Stride, Corcept Therapeutics, Valaris, and others, demonstrating its agile investment strategy and responsiveness to market dynamics.
- Earnings Target Confirmation: Independent Bank targets a net interest margin of 3.90%-3.95% for Q4 2026 while reaffirming a 1.40% return on assets goal, reflecting confidence in its future financial performance.
See More
PAR Technology Launches PAR Intelligence Platform
- Platform Launch: PAR Technology has introduced the PAR Intelligence platform, designed to enhance profitability for multi-unit operators by leveraging a unique data advantage accumulated over two decades, covering over 150,000 locations and processing 12 billion transactions annually.
- Execution Capability: Unlike traditional AI solutions that stop at insights, PAR Intelligence executes high-impact actions to bridge the 3.6x profitability gap between the best and worst stores, thereby improving overall business performance.
- Diverse Agent Functions: The platform features multiple AI-driven agents, such as the Insights Agent and Offers Agent, which automatically identify operational gaps and generate targeted marketing campaigns, reducing manual effort and increasing operational efficiency.
- Future Expansion Plans: PAR Technology plans to continue expanding the capabilities of the intelligence platform in the coming months by adding more agents and deeper orchestration, aiming to enhance the commercial performance of multi-unit operations and ensure that every store's profitability potential is fully realized.
See More
US Stocks Performance Review and Outlook
- Employment Data Expectations: ADP is set to release employment data at 8:15 a.m. ET, with a consensus estimate of 39,000 new jobs in the private sector, which will provide a crucial indicator of economic health and could influence investor confidence and market trends.
- Retail Sales Growth: Retail sales figures are expected to be released at 8:30 a.m., with a general forecast of a 0.5% increase, a data point that will directly impact consumer spending and the outlook for economic recovery, potentially guiding a market rebound.
- Corporate Earnings Dynamics: Cal-Maine, Conagra, and Lamb Weston are scheduled to report earnings before the bell, with Cal-Maine's stock flat over the past three months, Conagra down 9%, and Lamb Weston showing no significant change, all of which will affect investor sentiment towards the food sector.
- Market Performance Review: In the first quarter, the Russell 2000 index rose by 0.58%, making it the best performer among major indices, while the S&P 500 and Nasdaq 100 fell by 4.63% and 5.98%, respectively, reflecting market volatility and cautious investor sentiment.
See More
U.S. Stocks Decline Amid Escalating Geopolitical Tensions
- Oil Price Surge: The escalation of geopolitical tensions between the U.S. and Iran has pushed Brent crude oil prices above $100 per barrel, leading to significant declines in major indices and severely rattling investor confidence.
- Consumer Confidence Decline: The University of Michigan's consumer survey indicates a drop to a three-month low, with year-ahead inflation expectations rising to 3.8%, reflecting households' concerns about the economic outlook, which may suppress consumer spending.
- Poor Stock Performance: Hardware & Infrastructure company Pure Storage (NYSE:PSTG) fell 6.1%, while PAR Technology (NYSE:PAR) and IMAX (NYSE:IMAX) dropped 5.4% and 5% respectively, indicating a weakening market sentiment towards these companies.
- Uncertain Economic Outlook: Richmond Fed President Tom Barkin noted that the 'fog of war' has deepened economic uncertainty, and historically, oil price shocks are highly correlated with recessions, potentially leading to reduced corporate investment and hiring, further straining an already fragile economy.
See More
